ACTRN12613000455763Completed未知
Botulinum toxin injection for vocal cord dysfunction in asthma - benefits on symptoms and laryngeal imaging
Monash Medical Centre0 sites12 target enrollmentStarted: April 19, 2013Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 12
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Non-randomised trial
- Primary Purpose
- Treatment
- Masking
- Open (masking not used)
Eligibility Criteria
- Ages
- 18 Years to 75 Years (—)
- Sex
- All
Inclusion Criteria
- •Difficult-to-treat asthma unresponsive to optimised treatments,
- •Vocal cord dysfunction on imaging,
- •ACT score <15
Exclusion Criteria
- •Allergy to botulinum toxin
- •Other known laryngeal disease
Investigators
Similar Trials
Not yet recruiting
Phase 4
BOTOX for vocal cord dysfunction in severe asthmaSevere asthmaVocal cord DysfunctionRespiratory - AsthmaACTRN12611001270909Prof Philip Bardin46
Completed
Phase 2
Botulinum toxin treatment for orofacial pain, bruxism or occlusal dysesthesia: (phase 2 patient study) Effect for the patientsorofacial pain, bruxism, occlusal dysethesiaJPRN-UMIN000009827Tokushima University Hospital4
Active, not recruiting
Phase 1
Block of the neural structure otic ganglion in patients with chronic cluster headacheCluster headacheEUCTR2016-004213-28-NODepartment of Neuroscience, NT10
Completed
Not Applicable
Botulinum toxin in the treatment of orofacial tardive dyskinesias: a single blind studyTardive dyskinesiaDystoniaISRCTN81508784Parnassia Psycho-medical Centre (Netherlands)14
Completed
Phase 2
Botulinum injections for hand tremorCTRI/2018/02/011721All India Institute of Medical Sciences New Delhi30